Homepage
Healthcare · Medical - Instruments & Supplies · Canada · Updated May 11, 11:00am
$0.79
Price
$84.5M
Market Cap
24
Employees
0.31
Beta
Mohammed Jiwan
CEO
Business Description
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Business History
Price Overview
Last updated: May 11, 2026 12:49pm (just now)$0.86
+0.10 (+13.26%)
Day Range
$0.76 – $0.87
52-Week Range
$0.40 – $1.72
50-Day MA
$0.56
200-Day MA
$0.72
Volume
207,997.88
Share Structure
Outstanding
107,543,555.00
Float
102,677,209.00
Free Float
95.5%
High free float
— 95.5% of shares trade freely, ~4.5% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-7.85
Stock Price: $0.79
EPS (Diluted): -0.10
EPS (Diluted): -0.10
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
11.15
Stock Price: $0.79
Total Equity: $14.75M
Shares: 102,977,860
Total Equity: $14.75M
Shares: 102,977,860
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-14.66
Market Cap: $84.46M
Total Debt: $346,747
Cash: $121,481
EBITDA: -$9.35M
Total Debt: $346,747
Cash: $121,481
EBITDA: -$9.35M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$165.0M
Market Cap: $84.46M
Total Debt: $346,747
Cash: $121,481
Total Debt: $346,747
Cash: $121,481
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
22.1%
Gross Profit: $192,485
Revenue: $872,495
Revenue: $872,495
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-1,100.4%
Operating Income: -$9.60M
Revenue: $872,495
Revenue: $872,495
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-1,150.7%
Net Income: -$10.04M
Revenue: $872,495
Revenue: $872,495
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-61.3%
Net Income: -$10.04M
Total Equity: $14.75M
Total Equity: $14.75M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-61.5%
Operating Income: -$9.60M
Tax Rate: 0.0%
Equity: $14.75M
Total Debt: $346,747
Cash: $121,481
Tax Rate: 0.0%
Equity: $14.75M
Total Debt: $346,747
Cash: $121,481
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.25
Current Assets: $4.37M
Current Liabilities: $3.49M
Current Liabilities: $3.49M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.02
Short-Term Debt: $346,747
Long-Term Debt: $0.00
Total Debt: $346,747
Total Equity: $14.75M
Long-Term Debt: $0.00
Total Debt: $346,747
Total Equity: $14.75M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.01
Revenue: $872,495
Shares: 102,977,860
Shares: 102,977,860
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$0.14
Total Equity: $14.75M
Shares: 102,977,860
Shares: 102,977,860
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.06
Operating CF: -$6.28M
CapEx: -$1,398
Shares: 102,977,860
CapEx: -$1,398
Shares: 102,977,860
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.79
Stock Price: $0.79
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$10.04M
Net Income: -$10.04M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares ZTEK against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2,355 | $339,666 | $72,855 | $29,816 | $872,495 |
| Cost of Revenue | $196,028 | $376,787 | $853,336 | $331,080 | $680,010 |
| Gross Profit | $-193,673 | $-37,121 | $-780,481 | $-301,264 | $192,485 |
| Operating Expenses | $4.1M | $12.5M | $13.9M | $11.7M | $9.8M |
| Operating Income | -$4.3M | -$12.6M | -$14.7M | -$12.0M | -$9.6M |
| Net Income | -$3.9M | -$31.7M | -$14.4M | -$11.7M | -$10.0M |
| EBITDA | -$4.0M | -$31.0M | -$13.8M | -$11.1M | -$9.3M |
| EPS | $-0.05 | $-0.42 | $-0.14 | $-0.12 | $-0.10 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3.1M | $21.2M | $10.4M | $384,912 | $121,481 |
| Total Current Assets | $3.4M | $25.5M | $18.0M | $4.6M | $4.4M |
| Total Assets | $30.3M | $36.0M | $33.3M | $16.7M | $18.4M |
| Current Liabilities | $2.5M | $1.8M | $2.4M | $1.3M | $3.5M |
| Long-Term Debt | $0 | $797,657 | $0 | $191,277 | $0 |
| Total Liabilities | $2.8M | $2.7M | $2.9M | $1.8M | $3.6M |
| Total Equity | $27.5M | $33.2M | $30.4M | $14.9M | $14.7M |
| Retained Earnings | -$20.5M | -$41.7M | -$66.2M | -$56.6M | -$83.9M |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$1.8M | -$8.0M | -$13.0M | -$5.9M | -$6.3M |
| Capital Expenditure | $-254,282 | -$4.0M | -$2.3M | $-236,298 | $-1,398 |
| Free Cash Flow | -$2.0M | -$12.0M | -$15.2M | -$6.2M | -$6.3M |
| Acquisitions (net) | $0 | $0 | $0 | $7,382 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $-301,815 | $0 |
| Net Change in Cash | $2.3M | $23.6M | -$16.3M | $268,592 | -$3.4M |
Analyst Estimates (Annual)
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue |
$998,579 $998,579 – $998,579
|
$3.5M $3.5M – $3.5M
|
$14.0M $14.0M – $14.0M
|
| EBITDA |
$-998,579 $-998,579 – $-998,579
|
-$3.5M -$3.5M – -$3.5M
|
-$14.0M -$14.0M – -$14.0M
|
| Net Income |
-$10.3M -$10.3M – -$10.3M
|
-$15.4M -$15.4M – -$15.4M
|
-$10.3M -$10.3M – -$10.3M
|
| EPS | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +14,323.2% | -78.6% | -59.1% | +2,826.3% |
| Gross Profit Growth | +80.8% | -2,002.5% | +61.4% | +163.9% |
| Operating Income Growth | -191.2% | -16.6% | +18.3% | +19.9% |
| Net Income Growth | -719.3% | +54.5% | +18.8% | +14.2% |
| EBITDA Growth | -674.7% | +55.7% | +19.4% | +15.7% |
No community reviews yet for ZTEK.
Be the first — export the analysis to your AI and contribute back.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27